follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeHealthBiotechnology

      Biotechnology

      The biotechnology sector focuses on developing drugs predominantly for the Healthcare sector. 

      These companies make products from living organisms such as plant life and,  through biotechnology, are developing treatment or cures for a specific ailment.

      Examples of biotechnology companies include AVEO, Aeterna Zentaris, and Sorrento Therapeutics.

      DOVA stock
      Biotechnology

      DOVA Stock Climbs 38% on Buyout News from Swedish Drugmaker

      Sep 30 Caroline Harris
      DOVA stock climbed Monday after Dova Pharmaceuticals (NASDAQ:DOVA) announced a buyout offer from a Swedish drugmaker, Orphan Biovitrum. Here’s everything we know about the deal, from start to finish. DOVA Stock Goes Flying on Buyout ... [Read]
      TROV stock
      Biotechnology

      TROV Stock Soars 22% on Positive Mid-Stage Data at ESMO

      Sep 30 Ankit Singhania
      TROV stock is one of the biggest biotech stock gainers this morning after TrovaGene Inc (NASDAQ:TROV) reported positive results from its Phase 1b/2 study of onvansertib. Key Details Companies in the therapeutics space strive for ... [Read]
      ACHN stock
      Biotechnology

      ACHN Stock Zooms 17% as FDA Grants BTD for Danicopan

      Sep 25 Ankit Singhania
      ACHN stock is leading in the biotech sector after Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that the FDA has granted Breakthrough Therapy Designation (BTD) for danicopan (ACH-4471). Investors Cheer the News When a pharmaceutical company releases ... [Read]
      OVID stock
      Biotechnology

      OVID Stock Soars 40% in 2 Sessions on Preliminary Drug Results

      Sep 24 Ankit Singhania
      OVID stock is one of the biggest penny stock gainers in the biotech sector this week after Ovid Therapeutics Inc (NASDAQ:OVID) reported preliminary results from a Phase 2 open-label extension study. Positive Momentum Ovid Therapeutics ... [Read]
      TNXP stock
      Biotechnology

      TNXP Stock Soars After Announcing License Deal for TNX-1700

      Sep 17 Ankit Singhania
      Positive news with regards to a cancer medicine almost always sends the stock of a pharmaceutical company higher, and that is what happened with TNXP stock in Tuesday’s trading session. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) ... [Read]
      KPTI Stock
      Biotechnology

      KPTI Stock Climbs Following $150 Million USD Royalty Agreement

      Sep 16 Caileam Raleigh
      Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has announced that it is entering a royalty agreement with HealthCare Royalty Partners, boosting KPTI stock. Karyopharm, a Massachusettes-based pharmaceutical firm, will receive an initial $75 million USD by the end of ... [Read]
      ALDR stock
      Biotechnology

      ALDR Stock Hits 2-Year High on Lundbeck Acquisition News

      Sep 16 Ankit Singhania
      ALDR stock is the biggest gainer in the biotech space on the news that H. Lundbeck A/S will acquire Alder BioPharmaceuticals Inc (NASDAQ:ALDR) for $2 billion. Solid Boost for Shareholders When it comes to the ... [Read]
      LXRX stock
      Biotechnology

      LXRX Stock Soars 75% This Week: Terminates Agreement with Sanofi

      Sep 13 Ankit Singhania
      LXRX stock is making a big move this week, with a gain of over 75% this week after Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ended a collaboration agreement with Sanofi (NASDAQ:SNY). Sanofi News Gives Boost The pharmaceutical ... [Read]
      AVEO stock
      Biotechnology

      AVEO Stock Flies 40% on Impressive Tivozanib Data

      Sep 10 Ankit Singhania
      AVEO stock is gaining momentum this morning after AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported results from the second prespecified analysis of overall survival in the TIVO-3 trial. Boost for Investors Over the course of the past ... [Read]
      NTRP stock
      Biotechnology

      NTRP Stock Plunges 80% on Failed Alzheimer’s Treatment Study

      Sep 9 Caroline Harris
      Neurotrope, Inc. (NASDAQ:NTRP) is not starting the week off on the right foot. After announcing that its Alzheimer’s drug failed in its latest trial, NTRP stock tumbled around 80% Monday. Here’s what we know. NTRP ... [Read]

      Posts pagination

      « 1 … 9 10 11 … 32 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767